Publikationen in Zusammenarbeit mit Forschern von Medical University of Vienna (20)

2024

  1. Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma

    American Journal of Hematology

2023

  1. Alginate sulfate-nanoparticles loaded with hepatocyte growth factor and insulin-like growth factor-1 improve left ventricular repair in a porcine model of myocardial ischemia reperfusion injury

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 83-91

  2. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422

  3. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  4. European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)

    Neuro-oncology, Vol. 25, Núm. 1, pp. 37-53

2022

  1. Choice of vector and surgical approach enables efficient cochlear gene transfer in nonhuman primate

    Nature Communications, Vol. 13, Núm. 1

  2. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

    The Lancet Oncology, Vol. 23, Núm. 1, pp. 77-90

  3. Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort

    Neuro-oncology, Vol. 24, Núm. 10, pp. 1726-1735

2021

  1. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation

    Nature Genetics, Vol. 53, Núm. 9, pp. 1311-1321

2020

  1. Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease

    Journal of hypertension, Vol. 38, Núm. 10, pp. 2036-2042

  2. Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction

    Circulation, Vol. 142, Núm. 19, pp. 1831-1847

  3. Wnt signaling and Loxl2 promote aggressive osteosarcoma

    Cell Research, Vol. 30, Núm. 10, pp. 885-901

2019

  1. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage

    Gut, Vol. 68, Núm. 3, pp. 533-546

  2. Recent advances in signal integration mechanisms in the unfolded protein response [version 1; peer review: 2 approved]

    F1000Research, Vol. 8

2017

  1. Global position paper on cardiovascular regenerative medicine

    European Heart Journal

2016

  1. Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome

    Annals of Oncology, Vol. 27, Núm. 9, pp. 1788-1793

  2. Intralymphatic CCL21 Promotes Tissue Egress of Dendritic Cells through Afferent Lymphatic Vessels

    Cell Reports, Vol. 14, Núm. 7, pp. 1723-1734

2014

  1. Awareness and understanding of cancer immunotherapy in Europe

    Human Vaccines and Immunotherapeutics, Vol. 10, Núm. 7, pp. 1828-1835

  2. Therapeutic vaccines for cancer: An overview of clinical trials

    Nature Reviews Clinical Oncology, Vol. 11, Núm. 9, pp. 509-524

2009

  1. Prognostic factors and outcomes for osteosarcoma: An international collaboration

    European Journal of Cancer, Vol. 45, Núm. 13, pp. 2367-2375